Latest Insider Transactions at Lucid Diagnostics Inc. (LUCD)
This section provides a real-time view of insider transactions for Lucid Diagnostics Inc. (LUCD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Lucid Diagnostics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Lucid Diagnostics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 07
2024
|
Lishan Aklog Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+25.53%
|
-
|
|
May 07
2024
|
Dennis M Mcgrath Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+27.71%
|
-
|
|
May 07
2024
|
Shaun O'Neil President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+43.16%
|
-
|
|
May 07
2024
|
Michael Adam Gordon General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+50.0%
|
-
|
|
Feb 15
2024
|
Pa Vmed Inc. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
3,331,747
-9.62%
|
-
|
|
Jan 26
2024
|
Pa Vmed Inc. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
3,331,771
+8.78%
|
$3,331,771
$1.4 P/Share
|
|
Sep 26
2023
|
Stanley Lapidus Director |
SELL
Open market or private sale
|
Direct |
29,747
-8.2%
|
$29,747
$1.45 P/Share
|
|
Sep 25
2023
|
Stanley Lapidus Director |
SELL
Open market or private sale
|
Direct |
200
-0.15%
|
$200
$1.43 P/Share
|
|
Sep 21
2023
|
Stanley Lapidus Director |
SELL
Open market or private sale
|
Direct |
100
-0.08%
|
$100
$1.44 P/Share
|
|
Sep 20
2023
|
Stanley Lapidus Director |
SELL
Open market or private sale
|
Direct |
3,817
-1.41%
|
$3,817
$1.45 P/Share
|
|
Nov 30
2022
|
Pa Vmed Inc. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
3,375,230
+1.59%
|
$6,750,460
$2.12 P/Share
|
|
Sep 20
2022
|
Stanley Lapidus Director |
SELL
Open market or private sale
|
Direct |
33,864
-10.56%
|
$33,864
$1.71 P/Share
|
|
Jan 07
2022
|
Lishan Aklog Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+8.77%
|
-
|
|
Jan 07
2022
|
Dennis M Mcgrath Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+8.77%
|
-
|
|
Oct 18
2021
|
Pa Vmed Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
571,428
+2.01%
|
$7,999,992
$14.0 P/Share
|
|
Oct 18
2021
|
Ronald M Sparks Director |
BUY
Grant, award, or other acquisition
|
Direct |
84,660
+50.0%
|
-
|